779353-65-0 Usage
General Description
3-((5-chloro-3-ethylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide is a chemical compound with potential pharmaceutical applications. It contains a pyridine ring with a nitrogen atom, a pyrazole ring with a chlorine atom and an ethyl group, and a pyrimidine ring with an amino group and an ethyl group. Additionally, it consists of a pyridine 1-oxide functional group. 3-((5-chloro-3-ethylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide's structure suggests it may have biological activity, and it could be a potential candidate for further development as a drug for various medical conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 779353-65-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,9,3,5 and 3 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 779353-65:
(8*7)+(7*7)+(6*9)+(5*3)+(4*5)+(3*3)+(2*6)+(1*5)=220
220 % 10 = 0
So 779353-65-0 is a valid CAS Registry Number.
779353-65-0Relevant articles and documents
Discovery of dinaciclib (SCH 727965): A potent and selective inhibitor of cyclin-dependent kinases
Paruch, Kamil,Dwyer, Michael P.,Alvarez, Carmen,Brown, Courtney,Chan, Tin-Yau,Doll, Ronald J.,Keertikar, Kerry,Knutson, Chad,McKittrick, Brian,Rivera, Jocelyn,Rossman, Randall,Tucker, Greg,Fischmann, Thierry,Hruza, Alan,Madison, Vincent,Nomeir, Amin A.,Wang, Yaolin,Kirschmeier, Paul,Lees, Emma,Parry, David,Sgambellone, Nicole,Seghezzi, Wolfgang,Schultz, Lesley,Shanahan, Frances,Wiswell, Derek,Xu, Xiaoying,Zhou, Quiao,James, Ray A.,Paradkar, Vidyadhar M.,Park, Haengsoon,Rokosz, Laura R.,Stauffer, Tara M.,Guzi, Timothy J.
scheme or table, p. 204 - 208 (2010/12/20)
Inhibition of cyclin-dependent kinases (CDKs) has emerged as an attractive strategy for the development of novel oncology therapeutics. Herein is described the utilization of an in vivo screening approach with integrated efficacy and tolerability paramete
